Work

Abstract PS3-10-26: Long-term outcomes of two her2 vaccines to prevent recurrence in patients with her-2 positive early stage breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-10-26

Authors: H. S. Han, A. Aldrich, R. Weslowski, C. Fisher, S. Gandhi, W. R. Gwin, M. Kowzun, K. Gogineri, H. Soliman, R. Costa, H. Liu, J. Whiting, M. Schell, M. L. Disis, B. Czerniecki

Institutions: Moffitt Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Indiana University School of Medicine, Indiana University, University of Washington, Rutgers Cancer Institute, Emory University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129679931

Cites:

Cited by:

Related to: